{"filing":{"accession_number":"0001434265-26-000108","cik":"0001434265","ticker":"GNMSF","company_name":"GENMAB A/S","form":"6-K","filing_date":"2026-08-06","report_date":"2026-06-30","primary_document":"gmab-20260630.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1434265/000143426526000108/gmab-20260630.htm"},"events":[{"id":24534,"run_id":22241,"accession_number":"0001434265-26-000108","anchor_item_number":null,"event_type":"periodic_interim","event_domain":"periodic","is_material":true,"confidence":0.95,"summary":"This is Genmab's interim report for the six months ended June 30, 2026, furnished as Exhibit 99.1 to the Form 6-K. The document presents consolidated financial statements, revenue breakdowns by product and partner, and operational highlights for H1 2026 compared to H1 2025. Although it includes clinical progress announcements (epcoritamab Phase 3 results, Rina-S data), the core disclosure is a periodic interim financial report covering a six-month period, not a discrete earnings release event. Per the taxonomy guidance, periodic financial reports are deferred for separate processing and classified as `periodic_interim` rather than `earnings_release`.","company_name":"GENMAB A/S","ticker":"GNMSF","filing_date":"2026-08-06","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":25128,"accession_number":"0001434265-26-000108","item_number":null,"item_title":null,"event_type":"periodic_interim","event_domain":"periodic","is_material":true,"confidence":0.95,"reasoning":"This is Genmab's interim report for the six months ended June 30, 2026, furnished as Exhibit 99.1 to the Form 6-K. The document presents consolidated financial statements, revenue breakdowns by product and partner, and operational highlights for H1 2026 compared to H1 2025. Although it includes clinical progress announcements (epcoritamab Phase 3 results, Rina-S data), the core disclosure is a periodic interim financial report covering a six-month period, not a discrete earnings release event. Per the taxonomy guidance, periodic financial reports are deferred for separate processing and classified as `periodic_interim` rather than `earnings_release`.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:06:41.732293+00:00","company_name":"GENMAB A/S","ticker":"GNMSF","filing_date":"2026-08-06"}]}